Feb 3, 2025 · IPO Watch: Veeda Clinical Research has refiled its draft red herring prospectus for an IPO with SEBI. Founded in 2004, the company offers clinical trial services globally, with a revenue growth of ...

Feb 3, 2025 · CX Partners backed Veeda Clinical Research, a full-service contract research organization (CRO) has refiled its Draft Red Herring Prospectus (DRHP) with capital markets regulator, Securities and Exchange Board of India (SEBI) to raise funds through Initial Public Offering (), sources told ET. The company had earlier …

Jan 3, 2025 · Veeda Lifesciences represents the brand that integrates Veeda Clinical Research, Health Data Specialists, and Bioneeds India, showcasing research services across various stages of the drug development value chain from discovery and preclinical to late-phase development.

With more than a decade of experience, Veeda CRO in India has now become one of the most desired partners to the Pharmaceutical fraternity globally for conducting their clinical studies to deliver safe and quality clinical research solutions with no compromise on ethical practices.

Read about Veeda Group's acquisition of HEADS, enhancing capabilities in clinical research and strengthening its global footprint in healthcare innovation.

Veeda clinical research awarded as best quality clinical research organisation in India by World quality congress & awards 2019. Veeda Clinical Research reconfirms quality credentials with its seventh successful inspection by ANVISA (Brazilian Regulatory Agency)

Mar 26, 2024 · Veeda Clinical Research Limited ("Veeda") is one of the largest independent, full-service clinical research organizations, headquartered in Ahmedabad, India. Veeda offers a range of...

Feb 14, 2024 · Under the leadership of Ajay Tandon and the foundational work of Dr Kiran Marthak, Indian firm Veeda Clinical Research has strategically expanded its capabilities and global footprint.

We partner with innovator and generic companies using our high-quality infrastructure and a global network of clinical trial sites, to launch novel therapies and new products for patients...

Feb 3, 2025 · Veeda Clinical Research: Veeda Clinical Research has refiled its IPO papers with SEBI, planning to raise funds through a fresh issue and offer-for-sale. The proceeds will support capital expenditure, subsidiary investments, debt repayment, and business growth. The IPO will follow a book-building process.